Boston Scientific to acquire Endo’s Medical device business

Reportedly, the deal is estimated to be valued at around $2 billion


Endo Pharmaceuticals has put its AMS business unit for sale in August 2014

According to reports, Boston Scientific is reportedly close to acquiring the AMS (American Medical Systems) medical device business of Endo Pharmaceuticals for around $2 billion

Endo International acquired AMS for $2.9 billion in 2011. Three years after the acquisition it put up AMS for sale at a discount to its acquisition price in August 2014.

Reportedly, Endo plans to divest its AMS unit so that it can focus on its core market-leading products, which primarily include pharmaceuticals. Pharmaceuticals comprises of over 80 percent of the total revenue generated by Endo.


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email